Intestinal Microbiome Modulation of Therapeutic Efficacy of Cancer Immunotherapy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The gut microbiome influences cancer therapy response. Fecal microbiome transplants show promise in improving patient outcomes for cancer immunotherapy, with encouraging results from early clinical trials.
Area Of Science
- Microbiology
- Oncology
- Immunology
Background
- Bacteria are linked to cancer development and progression.
- The gut microbiome significantly impacts cancer treatment effectiveness.
- Machine learning models show moderate success in predicting therapy response using bacterial data.
Purpose Of The Study
- To explore the role of the gut microbiome in cancer therapy.
- To evaluate the potential of microbiome modulation for enhancing immunotherapy.
- To summarize findings from clinical trials investigating fecal microbiome transplantation.
Main Methods
- Analysis of bacterial associations with cancer.
- Development of machine learning models for response prediction.
- Review of clinical trials on fecal microbiome transplantation in cancer patients.
Main Results
- Gut microbiome modulation is a key factor in cancer therapy response.
- While single bacterial interventions have not yet succeeded, fecal microbiome transplants show promise.
- Early clinical studies, including randomized trials, report encouraging outcomes using fecal transplants.
Conclusions
- Targeting the gut microbiome is a viable strategy to improve cancer immunotherapy.
- Fecal microbiome transplantation represents a promising therapeutic approach for cancer patients.
- Further research and larger trials are warranted to confirm the efficacy of microbiome-based therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...